large molecule rage inhibitor ttp4000 Search Results


large molecule rage inhibitor ttp4000  (TransTech Pharma)
90
TransTech Pharma large molecule rage inhibitor ttp4000
Proposed schematic of the relationship between soluble <t>RAGE</t> and neutrophilic inflammation in chronic airways disease. Epithelial damage (1) caused by environmental insults induces the release of DAMPs (e.g. the RAGE ligands HMGB1, SAA) (2). DAMPs induce recruitment and activation of neutrophils in the airway space (3). DAMPs might also act in an autocrine manner to activate RAGE on airway epithelial cells (4), leading to the generation of further DAMPs (5), thus amplifying the inflammatory response. Activated neutrophils up-regulate the RAGE ligand Mac-1/CD11b on their surface and might therefore interact with airway epithelial cells via a RAGE-dependent mechanism (6). Neutrophil-derived proteases degrade soluble RAGE (7), the <t>endogenous</t> <t>inhibitor</t> of RAGE signalling (8), leading to unopposed neutrophil recruitment, activation and persistence in the airways and a failure to resolve the inflammatory response.
Large Molecule Rage Inhibitor Ttp4000, supplied by TransTech Pharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/large molecule rage inhibitor ttp4000/product/TransTech Pharma
Average 90 stars, based on 1 article reviews
large molecule rage inhibitor ttp4000 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Proposed schematic of the relationship between soluble RAGE and neutrophilic inflammation in chronic airways disease. Epithelial damage (1) caused by environmental insults induces the release of DAMPs (e.g. the RAGE ligands HMGB1, SAA) (2). DAMPs induce recruitment and activation of neutrophils in the airway space (3). DAMPs might also act in an autocrine manner to activate RAGE on airway epithelial cells (4), leading to the generation of further DAMPs (5), thus amplifying the inflammatory response. Activated neutrophils up-regulate the RAGE ligand Mac-1/CD11b on their surface and might therefore interact with airway epithelial cells via a RAGE-dependent mechanism (6). Neutrophil-derived proteases degrade soluble RAGE (7), the endogenous inhibitor of RAGE signalling (8), leading to unopposed neutrophil recruitment, activation and persistence in the airways and a failure to resolve the inflammatory response.

Journal: British Journal of Pharmacology

Article Title: RAGE: a new frontier in chronic airways disease

doi: 10.1111/j.1476-5381.2012.01984.x

Figure Lengend Snippet: Proposed schematic of the relationship between soluble RAGE and neutrophilic inflammation in chronic airways disease. Epithelial damage (1) caused by environmental insults induces the release of DAMPs (e.g. the RAGE ligands HMGB1, SAA) (2). DAMPs induce recruitment and activation of neutrophils in the airway space (3). DAMPs might also act in an autocrine manner to activate RAGE on airway epithelial cells (4), leading to the generation of further DAMPs (5), thus amplifying the inflammatory response. Activated neutrophils up-regulate the RAGE ligand Mac-1/CD11b on their surface and might therefore interact with airway epithelial cells via a RAGE-dependent mechanism (6). Neutrophil-derived proteases degrade soluble RAGE (7), the endogenous inhibitor of RAGE signalling (8), leading to unopposed neutrophil recruitment, activation and persistence in the airways and a failure to resolve the inflammatory response.

Article Snippet: Nevertheless, another large molecule RAGE inhibitor (TTP4000), which is a fusion between the ligand binding domains of RAGE and IgG, is still under clinical development and is entering a clinical study in Alzheimer's patients (Transtech Pharma Inc).

Techniques: Activation Assay, Derivative Assay